According to the results shown in Fig. 1A, we found that gp96 concentrations in the plasma increased significantly in all COVID-19 patients (912.7 ± 219.7), compared with those observed in healthy controls (467.5 ± 178.6). This evidence concerns the gene HSP90B1 and COVID-19.